Zymeworks (ZYME) Receivables - Other (2022 - 2026)
Zymeworks recorded quarterly Receivables - Other of $1.6 million in Q1 2026, down 43.53% quarter-over-quarter from $2.8 million in Q4 2025, and up 688.83% year-over-year from $197000.0 in Q1 2025.
Zymeworks' Receivables - Other history runs 5 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Receivables - Other rose 688.83% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 688.83% YoY), while the FY2025 annual figure was $2.8 million, up 2700.0% from the prior year.
- Receivables - Other came in at $1.6 million for Q1 2026 at Zymeworks, down from $2.8 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $3.0 million in Q3 2022 to a low of $100000.0 in Q4 2024.
- A 5-year average of $1.7 million and a median of $1.6 million in 2026 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other soared 2652.0% in 2025 and surged 688.83% in 2026, its largest moves.
- Zymeworks' Receivables - Other stood at $3.0 million in 2022, then changed by 0.0% to $3.0 million in 2023, then sank by 96.67% to $100000.0 in 2024, then jumped by 2652.0% to $2.8 million in 2025, then tumbled by 43.53% to $1.6 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $1.6 million, $2.8 million, and $971000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 971,000.00 |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 569,000.00 |
| Jun 30, 2025 | 569,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Mar 31, 2025 | 197,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Mar 31, 2023 | 3.00 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Sep 30, 2022 | 3.00 Mn |